# Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery

Study · id `cardio:ct-nct01171911` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01171911](<https://clinicaltrials.gov/study/NCT01171911>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01171911

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT01171911. Randomized; single masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2010-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT01171911, source copy `cardio:ctgov-nct01171911-2010-07-29`, retrieved 2026-10-26)
- Start date: 2010-10 (registry gives no type) (ClinicalTrials.gov record NCT01171911, source copy `cardio:ctgov-nct01171911-2010-07-29`, retrieved 2026-10-26)
- Primary completion: 2010-12 (anticipated) (ClinicalTrials.gov record NCT01171911, source copy `cardio:ctgov-nct01171911-2010-07-29`, retrieved 2026-10-26)
- Completion: 2010-12 (anticipated) (ClinicalTrials.gov record NCT01171911, source copy `cardio:ctgov-nct01171911-2010-07-29`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01171911, source copy `cardio:ctgov-nct01171911-2010-07-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01171911-2010-07-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery
- Condition: Acute Coronary Syndrome
- Condition: Coronary Artery Disease
- Intervention (Drug): Nicardipine , Esmolol
- Lead sponsor: Nanjing Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Nanjing Medical University (`cardio:org-nanjing-medical-university`)

## Provenance

Content hash: ecd82a17176641697d93fdf89846abbf8b0ecd100d862618d44d6c850698d20a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
